Home > Boards > US Listed > Biotechs > Synthetic Biologics, Inc. (SYN)

Need to get some of that low floater

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BooDog Member Profile
 
Followed By 193
Posts 20,089
Boards Moderated 4
Alias Born 08/03/06
160x600 placeholder
Synthetic Biologics Announces Extension of Compliance Plan Period by NYSE American PR Newswire (US) - 11/24/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/18/2020 6:04:49 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/17/2020 5:25:57 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/17/2020 5:25:37 PM
Synthetic Biologics Engages A.G.P./Alliance Global Partners as Advisor to Assist in Evaluating Strategic Options PR Newswire (US) - 11/16/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 3:40:24 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/12/2020 3:40:14 PM
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors PR Newswire (US) - 11/12/2020 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2020 5:01:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/10/2020 4:21:42 PM
Synthetic Biologics Reports 2020 Third Quarter Operational Highlights and Financial Results PR Newswire (US) - 11/10/2020 4:15:00 PM
Synthetic Biologics to Report 2020 Third Quarter Operational Highlights and Financial Results on November 10, 2020 PR Newswire (US) - 11/3/2020 4:30:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 10/28/2020 5:24:07 PM
Synthetic Biologics Provides Update on Investigator-Sponsored Phase 2b Clinical Study of SYN-010 in IBS-C Patients PR Newswire (US) - 10/2/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/18/2020 7:01:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 4:23:36 PM
Synthetic Biologics Reports 2020 Second Quarter Operational Highlights and Financial Results PR Newswire (US) - 8/6/2020 4:15:00 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/4/2020 5:02:27 PM
Synthetic Biologics Announces FDA Clearance of Investigational New Drug Application for SYN-020 Intestinal Alkaline Phosphata... PR Newswire (US) - 7/30/2020 7:00:00 AM
Synthetic Biologics to Report 2020 Second Quarter Operational Highlights and Financial Results on August 6, 2020 PR Newswire (US) - 7/29/2020 4:30:00 PM
Synthetic Biologics Announces Submission of IND Application to U.S. FDA for SYN-020 Intestinal Alkaline Phosphatase PR Newswire (US) - 6/30/2020 7:00:00 AM
Synthetic Biologics Enters into Exclusive Option to License Intellectual Property for Use of SYN-020 to Treat and Prevent Age... PR Newswire (US) - 5/27/2020 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/5/2020 4:39:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2020 4:16:43 PM
Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial Results PR Newswire (US) - 5/5/2020 4:15:00 PM
BooDog   Thursday, 03/14/19 10:45:36 AM
Re: None
Post # of 8159 
Need to get some of that low floater action! Boogity Boogity BOOGITY!!!!

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences